• The Ixiaro vaccine - Valneva bets on niche travel protection AD HOC NEWS Wed, 08 Jul 2026 13:03:06 GMT
• (VALN) Movement Within Algorithmic Entry Frameworks Stock Traders Daily Thu, 02 Jul 2026 23:04:02 GMT
• bronstein, gewirtz & grossman, llc is investigating valneva se (valn) and encourages investors to connect The National Law Review Thu, 02 Jul 2026 05:50:20 GMT
• Ixiaro from Valneva SE - travel vaccine quietly powers a niche market AD HOC NEWS Wed, 01 Jul 2026 19:07:13 GMT
• valn q1 2026 earnings: eps misses estimates amid thin revenue disclosure - energy earnings report dars.gov.et Wed, 01 Jul 2026 14:47:22 GMT
• IXIARO from Valneva SE - travel vaccine quietly anchors a niche but vital market AD HOC NEWS Wed, 01 Jul 2026 06:45:27 GMT
• The VLA2001 COVID-19 Vaccine - Valneva SE leans on boosted demand for updated protection AD HOC NEWS Tue, 30 Jun 2026 19:12:46 GMT
• bronstein, gewirtz & grossman, llc is investigating valneva se (valn) and encourages stockholders to connect The National Law Review Tue, 30 Jun 2026 15:19:28 GMT
• VLA15 Lyme disease vaccine from Valneva SE - late-stage data set up US filing push AD HOC NEWS Tue, 30 Jun 2026 15:15:03 GMT
• Valneva's Stock Bounces Nearly 3% Attempting to Recover from a Three-Month Slide Idéal Investisseur Tue, 30 Jun 2026 07:00:00 GMT
• Certain Ordinary Shares of Valneva SE are subject to a Lock-Up Agreement Ending on 30-JUN-2026. marketscreener.com Tue, 30 Jun 2026 00:25:29 GMT
• ixiaro from valneva se - japanese encephalitis protection for travelers AD HOC NEWS Mon, 29 Jun 2026 20:53:47 GMT
• valneva's stock bounces nearly 2% after a month marked by a 15% decline Idéal Investisseur Mon, 29 Jun 2026 12:43:00 GMT
• IXIARO from Valneva SE - classic Japanese encephalitis shot keeps its niche AD HOC NEWS Sun, 28 Jun 2026 20:05:04 GMT
• Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect The National Law Review Sun, 28 Jun 2026 14:27:34 GMT
• IXIARO from Valneva SE - travel vaccine with a clear safety profile AD HOC NEWS Sat, 27 Jun 2026 15:26:11 GMT
• valneva se sponsored adr actuals & estimates (nasdaq:valn) TradingView Fri, 26 Jun 2026 19:17:29 GMT
• valneva se (valn) shareholder/analyst call - slideshow (nasdaq:valn) 2026-06-26 Seeking Alpha Fri, 26 Jun 2026 04:02:07 GMT
• ixiaro from valneva se - focused protection for japanese encephalitis travelers Ad-hoc-news.de Thu, 25 Jun 2026 14:21:37 GMT
• valneva se (valn) financial health: profitability & balance sheet analysis TradingKey Thu, 25 Jun 2026 10:48:27 GMT
• Valneva Announces Successful Outcome of its Annual General Meeting Yahoo Finance Thu, 25 Jun 2026 07:00:00 GMT
• Valneva (Nasdaq: VALN) holders approve AGM items and elect new chair Stock Titan Thu, 25 Jun 2026 07:00:00 GMT
• Press Release: Valneva Announces Successful Outcome of Its Annual General Meeting Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• valneva shares drop 3.57% breaking support at €2.21 Idéal Investisseur Thu, 25 Jun 2026 07:00:00 GMT
• valneva se (valn) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• valneva se (valn) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• valneva’s twin catalysts: shigella data and lyme filing loom over a stock near multi-year lows aktiencheck.de Sun, 21 Jun 2026 13:42:00 GMT
• How (VALN) Movements Inform Risk Allocation Models Stock Traders Daily Sun, 21 Jun 2026 07:00:00 GMT
• valneva’s credibility test: stock near lows as lyme vaccine data gives conflicting signals aktiencheck.de Sat, 20 Jun 2026 12:14:00 GMT
• Valneva SE (VALN) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Thu, 18 Jun 2026 13:13:40 GMT
• why valneva’s ixiaro quietly sets the standard for travel vaccines AD HOC NEWS Thu, 18 Jun 2026 07:00:00 GMT
• valneva se (valn) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 05:57:22 GMT
• valneva se (valn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 02:21:17 GMT
• valneva se (valn) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 13:33:55 GMT
• valneva se (valn) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 11:57:09 GMT
• valneva se (valn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 11:26:36 GMT
• valneva se (valn) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 11:20:51 GMT
• valneva se (valn) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 11:20:06 GMT
• protective clarity for your vaccine shares with the valneva se investor focus Ad-hoc-news.de Wed, 17 Jun 2026 03:20:53 GMT
• Valneva SE (NASDAQ: VALN) registers 31.6M resale shares, warrants included Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Valneva SE - Files For Offer And Resale From Time To Time By Selling Securityholders Of Up 31.6 Million Ordinary Shares TradingView Tue, 16 Jun 2026 07:00:00 GMT
• single-dose protection: valneva’s ixchiq vaccine enters u.s. chikungunya market Ad-hoc-news.de Tue, 16 Jun 2026 07:00:00 GMT
• valneva se (valn) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• valneva se (valn) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• valneva se (valn) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• valneva se (valn) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• single-dose protection, valneva’s ixchiq chikungunya vaccine reaches us and eu markets AD HOC NEWS Mon, 15 Jun 2026 17:04:21 GMT
• ixiaro: valneva’s flagship japanese encephalitis travel vaccine in focus AD HOC NEWS Sun, 14 Jun 2026 14:08:09 GMT
• valneva's restructuring drive and share overhang collide with high-stakes lyme vaccine filing aktiencheck.de Sat, 13 Jun 2026 16:07:00 GMT
• valneva ixiaro: travel vaccine for japanese encephalitis explained for u.s. travelers AD HOC NEWS Thu, 11 Jun 2026 22:22:30 GMT
• valneva ixiaro travel vaccine explained for u.s. travelers Ad-hoc-news.de Wed, 10 Jun 2026 07:00:00 GMT
• valneva's stock breaks through its €2.26 support, extending its losing streak Idéal Investisseur Wed, 10 Jun 2026 07:00:00 GMT
• valneva shares drop 2% and approach key support at €2.26 Idéal Investisseur Mon, 08 Jun 2026 07:00:00 GMT
• valn q1 2026 earnings: eps misses estimates, revenue not disclosed, stock declines - retail earnings report Město Břeclav Mon, 08 Jun 2026 07:00:00 GMT
• Valneva Publishes Documentation for June 25, 2026 Annual General Meeting The Globe and Mail Sat, 06 Jun 2026 07:00:00 GMT
• valneva ixiaro japanese encephalitis vaccine for travelers Ad-hoc-news.de Sat, 06 Jun 2026 07:00:00 GMT
• Valneva (NASDAQ: VALN) details access to 2026 Annual General Meeting documents Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• valneva se (valn) q1 2026 earnings: wider-than-expected loss weighs on shares - slow growth warning dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• valneva's shares continue to fall, threatening key support at €2.26 Idéal Investisseur Fri, 05 Jun 2026 07:00:00 GMT
• vla.pa technical analysis | trend, signals & chart patterns | valneva se (epa:vla) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• Valneva Announces Availability of Documentation for its Annual General Meeting The Manila Times Thu, 04 Jun 2026 07:00:00 GMT
• valneva (nasdaq: valn) registers 31.8m shares, warrants tied to fda milestone Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• valneva:declaration of shares and voting rights - status as of may 31, 2026 Yahoo Finance Wed, 03 Jun 2026 16:00:00 GMT
• vla: lyme vaccine filing expected in autumn, with major catalysts ahead in lyme, ixiaro, and shigella TradingView Wed, 03 Jun 2026 14:33:32 GMT
• valneva announces availability of documentation for its annual general meeting Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• valneva shares drop 3.1%, under technical pressure Idéal Investisseur Tue, 02 Jun 2026 11:13:00 GMT
• Valneva Ramps Up June 2026 Investor and Medical Conference Presence The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• valneva (nasdaq: valn) highlights lyme vaccine and joins june investor events Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• valneva ixiaro travel vaccine: what us travelers should know AD HOC NEWS Sun, 31 May 2026 07:00:00 GMT
• How Valneva Se (VALN) Affects Rotational Strategy Timing Stock Traders Daily Sat, 30 May 2026 07:00:00 GMT
• valneva to participate in three investor conferences in june 2026 Idéal Investisseur Fri, 29 May 2026 07:39:00 GMT
• vla.pa technical analysis | trend, signals & chart patterns | valneva se (epa:vla) ChartMill Fri, 29 May 2026 07:00:00 GMT
• Valneva to Participate at U.S. and European Investor Conferences in June Yahoo Finance Thu, 28 May 2026 07:00:00 GMT
• vla15 lyme disease vaccine: what us travelers should know AD HOC NEWS Sun, 24 May 2026 19:24:25 GMT
• vla.pa technical analysis | trend, signals & chart patterns | valneva se (epa:vla) ChartMill Fri, 22 May 2026 07:00:00 GMT
• valneva reiseimpfstoff guidance for us travelers and clinics AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• vla.pa technical analysis | trend, signals & chart patterns | valneva se (epa:vla) ChartMill Thu, 21 May 2026 07:00:00 GMT
• (valn) and the role of price-sensitive allocations Stock Traders Daily Tue, 19 May 2026 07:00:00 GMT
• clearpoint neuro, valneva, rocket lab and other big stocks moving lower in wednesday's pre-market session MSN Mon, 18 May 2026 01:06:09 GMT
• Valneva SE 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:VALN) 2026-05-16 Seeking Alpha Sat, 16 May 2026 07:00:00 GMT
• Travel vaccine demand drops as Valneva cuts 15% workforce, citing geopolitical headwinds eciks.org Sat, 16 May 2026 07:00:00 GMT
• valneva se - depositary receipt (valn) price target decreased by 17.41% to 14.35 MSN Fri, 15 May 2026 09:43:58 GMT
• valneva se earnings missed by $0.24, revenue fell short of estimates Investing.com South Africa Fri, 15 May 2026 07:22:21 GMT
• €5.28: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results simplywall.st Fri, 15 May 2026 07:00:00 GMT
• clearpoint neuro, valneva, rocket lab and other big stocks moving lower in wednesday's pre-market session MSN Thu, 14 May 2026 20:29:26 GMT
• valneva se - depositary receipt (valn) price target decreased by 17.41% to 14.35 MSN Thu, 14 May 2026 15:54:43 GMT
• valneva axes up to 15% of its workforce as travel vaccine demand falls Citeline News & Insights Thu, 14 May 2026 14:26:03 GMT
• Valneva SE earnings missed by $0.24, revenue fell short of estimates Investing.com Thu, 14 May 2026 07:00:00 GMT
• valneva se (nasdaq:valn) q1 2026 earnings call transcript Insider Monkey Thu, 14 May 2026 07:00:00 GMT
• valneva se (inrlf) q1 2026 earnings call highlights: promising v GuruFocus Thu, 14 May 2026 01:49:33 GMT
• valneva tightens 2026 guidance and restructures as lyme vaccine nears regulatory filings TipRanks Wed, 13 May 2026 21:36:38 GMT
• valneva se reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 13 May 2026 20:49:00 GMT
• vla: lower q1 sales and losses prompt restructuring, with focus on lyme, chikungunya, and shigella vaccines TradingView Wed, 13 May 2026 14:38:14 GMT
• vla: q1 2026 revenues declined sharply, but cash reserves and restructuring support future growth TradingView Wed, 13 May 2026 11:50:25 GMT
• valneva se stock 12‑month price target cut to $13.4, implies 123% upside TradingView Wed, 13 May 2026 10:20:07 GMT
• valneva (valn) reports q1 loss and adjusts revenue guidance GuruFocus Wed, 13 May 2026 09:36:53 GMT
• valneva se reports results for the quarter ended march 31 - earnings summary TradingView Wed, 13 May 2026 07:32:44 GMT
• Valneva SE Stock 12‑Month Price Target Cut to $12.98, Implies 116% Upside TradingView Wed, 13 May 2026 07:00:00 GMT
• Earnings call transcript: Valneva SE Q1 2026 reports revenue decline, stock dips Investing.com Wed, 13 May 2026 07:00:00 GMT
• valneva (valn) q1 2026 revenue drops as guidance cut and restructuring begin Stock Titan Wed, 13 May 2026 07:00:00 GMT
• valneva reports first quarter 2026 financial results and provides corporate updates The Manila Times Wed, 13 May 2026 07:00:00 GMT
• valneva se (inrlf) q1 2026 earnings call highlights: promising v GuruFocus Wed, 13 May 2026 07:00:00 GMT
• vla: lower q1 revenues and net loss prompt cost cuts and revised guidance amid lyme vaccine uncertainty TradingView Wed, 13 May 2026 07:00:00 GMT
• french analyst ratings: aramis and valneva penalized following profit warnings marketscreener.com Wed, 13 May 2026 07:00:00 GMT
• valneva in the green despite guidance cut and restructuring marketscreener.com Wed, 13 May 2026 07:00:00 GMT
• valneva se revises earnings guidance for the year 2026 marketscreener.com Wed, 13 May 2026 05:00:00 GMT
• [schedule 13d/a] valneva se amended major shareholder report Stock Titan Tue, 12 May 2026 21:09:41 GMT
• [schedule 13g] valneva se passive investment disclosure (>5%) Stock Titan Tue, 12 May 2026 20:32:30 GMT
• valneva reports first quarter 2026 financial results and provides corporate updates Yahoo Finance Tue, 12 May 2026 07:00:00 GMT
• frazier funds disclose valneva holdings (valn) and warrant limits Stock Titan Tue, 12 May 2026 07:00:00 GMT
• valneva (valn) reports q1 loss and adjusts revenue guidance GuruFocus Tue, 12 May 2026 07:00:00 GMT
• valneva (valn) ownership shifts after eur84m eur84m reserved share offering Stock Titan Tue, 12 May 2026 07:00:00 GMT
• valneva se expected to post a loss of 11 cents a share - earnings preview TradingView Mon, 11 May 2026 07:58:02 GMT
Valneva SE(NASDAQ:VALN) 
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.
Website: https://valneva.com/
Founded: 2012
CEO: Thomas Lingelbach
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends